Manufacturers Life Insurance Company, The Poseida Therapeutics, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $108 Billion
- Q3 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Poseida Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 27,273 shares of PSTX stock, worth $259,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,273
Previous 28,520
4.37%
Holding current value
$259,093
Previous $83,000
6.02%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding PSTX
# of Institutions
103Shares Held
38.7MCall Options Held
377KPut Options Held
22.2K-
Pentwater Capital Management LP Naples, FL5.98MShares$56.8 Million0.18% of portfolio
-
Black Rock Inc. New York, NY4.91MShares$46.6 Million0.0% of portfolio
-
Silverarc Capital Management, LLC3.69MShares$35 Million2.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.66MShares$34.8 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.19MShares$20.8 Million0.0% of portfolio
About Poseida Therapeutics, Inc.
- Ticker PSTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 85,775,600
- Market Cap $815M
- Description
- Poseida Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for patients with high unmet medical needs. The company develops P-PSMA-101, an autologous chimeric antigen receptor T cell (CAR-T) product candidate that is in Phase I trial for the treatment of patients with metastatic castrate resistant ...